Literature DB >> 24748733

Protective Assessment of Euphorbia neriifolia and its Isolated Flavonoid Against N-nitrosodiethylamine-induced Hepatic Carcinogenesis in Male Mice: A Histopathological Analysis.

Veena Sharma1, Pracheta Janmeda1.   

Abstract

AIMS: The aim of this study was to examine the impacts of N-nitrosodiethylamine (DENA), a potent environment carcinogen on liver tissue of mice which was attenuated by isolated flavonoid and hydro-ethanolic extract of Euphorbia neriifolia (HEEN) leaves.
MATERIALS AND METHODS: Carcinogenicity was induced in albino mice by a single oral administration of DENA (50 mg/kg body weight). The HEEN (150 and 400 mg/kg body weight), butylated hydroxyanisole (BHA; 0.5 and 1%) and E. neriifolia flavonoid (ENF; 50 mg/kg body weight) were estimated to examine the possible anti-cancer potential.
RESULTS: DENA exposed animals showed alterations in normal hepatic histo-architecture, which comprised of necrosis (N), dilated sinusoids and vacuolization of the cells. Mice treated with E. neriifolia lower (ENL) and higher (ENH) dose and ENF before intoxicated with DENA showed that the liver cells were normal, with very little necrosis (Day 31). On the other hand, BHA higher (BHAH) and lower (BHAL) dose failed to diminish the abnormalities caused by the DENA.
CONCLUSION: Results of the present study suggests that the ENH and ENF protects the hepatic tissue against DENA-induced hepatic carcinoma. The results could also be expressed in the order of ENH> ENF> ENL> BHAH> BHAL.

Entities:  

Keywords:  Euphorbia neriifolia; N-nitrosodiethylamine; flavonoid; liver; necrosis

Year:  2014        PMID: 24748733      PMCID: PMC3989913          DOI: 10.4103/0971-6580.128790

Source DB:  PubMed          Journal:  Toxicol Int        ISSN: 0971-6580


INTRODUCTION

Cancer is one of the most dreaded diseases of the 20th century and spreading further with continuance and increasing incidence in 21st century. Hepatocarcinoma (HCC) is a major problem not only in developed countries, but also in most undeveloped countries. Hepatocellular carcinoma is considered to be the 5th most common ubiquitous deadliest liver cancer representing up to 83% of all cases and one of the most common lethal pathology world-wide with poor diagnosis.[1] It is one of the most frequent malignant tumors world-wide and a leading cause of cancer related deaths in the world and incidence of over 1 million cases every year <1.25 annually.[2] It accounts for about 90% of all primary liver cancers. HCC, a fatal malignancy represents 4% of all malignant tumors. It is induced by toxic industrial chemicals, and air pollutants as also, food additives and fungal toxins.[3] N-nitrosodiethylamine (DENA) is an N-Nitroso alkyl compound and was chosen as a carcinogenic model because this well-investigated, classic carcinogen is present in our environment and suggested to increase the generation of reactive oxygen species (ROS) that results oxidative stress or cellular injury.[45] DENA is reasonably anticipated to be a human carcinogen based on sufficient evidence of carcinogenicity in experimental animals.[45] Histopathology, the microscopic study of diseased tissue is an important tool in anatomical pathology, since accurate diagnosis of many diseases usually requires histopathological examination of samples. Several medicinal plants including Euphorbia neriifolia tend to reduce the severity of cancer and prescribed constituents of liver protective herbal drugs have been shown to inhibit DENA-induced hepato-carcinogenicity in experimental animals,[6789] but these studies did not report any histological changes during hepatocarcinogenesis induced by DENA. Moreover, no published information is available on the histological study of the use of E. neriifolia flavonoid (ENF) (2-[3,4-dihydroxy-5-methoxy-phenyl]-3,5-dihydroxy-6,7-dimethoxychromen-4-one) and hydro-ethanolic extract of E. neriifolia (HEEN) against hepatic carcinogenesis induced by DENA. Therefore, we examined the chemo preventive efficacy of E. neriifolia and its isolated flavonoid by ameliorating the hepatic carcinoma induced by DENA.

MATERIALS AND METHODS

Chemicals and reagents

DENA (CAS number: 55-18-5) was purchased from Sigma Chemical Co., USA. All other chemicals used for the study were of analytical grade and were purchased from reliable firms.

Preparation of HEEN

E. neriifolia leaves were collected from medicinal garden of Banasthali University, Banasthali and nearby areas of Banasthali (Latitude N-26°24’14.8414”; Longitude E-73°52’9.7194”), in the month of October, 2009 and taxonomically identified with the help of available literature and authenticated by botanist of Krishi Vigyan Kendra, Banasthali University, Banasthali (Rajasthan, India). A voucher specimen was deposited in the herbarium of department of bioscience and Biotechnology, Banasthali University (No. BVH-780141A). Shade dried leaves were powdered soxhlet extracted with 70% (v/v) ethanol and vacuum concentrated to dryness under reduced pressure at 60 ± 1°C. After drying in a hot air oven (40-45°C), it was stored in an air tight container in the refrigerator at 5°C. The residue was designated as HEEN and was used to assess hepato-protective activity.

Isolation of flavonoid from E. neriifolia

Dried leaves of E. neriifolia (500 g) were extracted successively with non-polar to polar to get respective extracts. Flavonoid contents and their presence were determined by the method of Harborne,[10] using quercetin as standard. Out of all extracts dark-brown sticky semi-solid ethanolic extract (48.9 g) contained bulk of flavonoids was used for chromatographic separation. The ethanol extract obtained was concentrated and chromatographed on silica plates by using n-butanol: acetic acid: water (2:2:6) as mobile phase. As a result three spots were resolved and nomenclatured as IF1, IF2 and IF3 having Rf values of 0.60, 0.79 and 0.90 respectively. The Rf of IF2 was coinciding with standard quercetin Rf value that was found to be 0.79. IF2 fraction carefully crystallized, gave solid pale yellow crystal, soluble in water and in organic solvents was designed as ENF. High performance thin layer chromatography and infra-red spectrum of ENF in KBr pellet confirmed the presence of hydroxyl (-OH) group with H-bonded primary alcohol in flavonoids. With the help of 1H NMR and MS the ENF was characterized as 2-(3,4-dihydroxy-5-methoxy- phenyl)-3,5-dihydroxy-6,7-dimethoxychromen-4-one. ENF was used to assess tissue-protective activity.

Experimental animals and treatment regimen

Healthy male Swiss albino mice (Mus musculus L.) procured from Chaudhary Charan Singh Haryana Agricultural University, Hissar (Haryana, India) were housed under standard laboratory conditions of temperature (22 ± 3°C), 50 ± 15% Relative humidity and photoperiod (12:12 h L: D cycle). Animals lead free access to standard food pellet diet (Hindustan Lever Limited, India) and tap water ad libitum. The studies were carried out in accordance with the guidelines given by Committee for the Purpose of Control and Supervision on Experiments on Animals (CPCSEA, Reg. No: IAEC/814 date. 23.01.2010). After 2 weeks of acclimatization, mice were randomly divided into seven groups of six mice each and were administered orally by gavage. Treatment regimen as follows: Group I: Normal control, Group II: Carcinogen control, received distilled water for 21 days and then single dose of DENA (50 mg/kg body weight) and left for 10 days, Group III: E. neriifolia lower (ENL; 150 mg/kg body weight/day) and Group IV: E. neriifolia higher (ENH; 400 mg/kg body weight/day) for 21 days, before being intoxicated with DENA, once, Group V: Butylatedhydroxyanisole lower (BHAL; 0.5% mg/kg body weight/day) and Group VI: Butylated hydroxyanisole higher (BHAH) (1% mg/kg body weight/day) for 21 days, dissolved in 0.5% acetone, before being intoxicated with DENA, once, Group VII: ENF (50 mg/kg body weight/day) for 21 days, dissolved in dH2O, before being intoxicated with DENA. Then, the animals were sacrificed on 10 day after DENA administration and the total duration of the experiment was of 31 days. The dose for DENA (Sigma-N0258-Material Safety Data Sheet, 2003),[67] BHA,[11] plant[67121314] and ENF[15] were selected on the basis of LD50 calculated in our own laboratory and other published reports.

Autopsy and isolation of organs

After 31 days of treatment, mice were deprived of food overnight and then on the next day they were sacrificed under light chloroform anaesthesia. After postpartum liver was excised immediately, washed, cleaned and rinsed in ice cold normal saline solution (0.9% NaCl, pH 7.4), until bleached of all the blood and blotted dry on filter paper sheets to remove blood. Proper care was taken to avoid damage of any part of tissue while departing from the body. Small portion of tissue was fixed in buffered formalin (10% formaldehyde diluted using normal saline) for histological studies.

Histopathological studies

Fixation was followed by washing the tissue in running water, dehydrated by graded series of alcohol, cleaned in xylene and stained in hematoxylin and eosin. Paraffin blocks with tissue were prepared and sections of about 3-5 μm in thickness were cut on rotatory microtome, paraffin ribbons with tissue taken on microscopic slides were dehydrated. These tissue sections were mounted and then examined for pathological alterations by light microscope (Model-Motic).[16]

RESULTS

Percentage of tissue carcinogenesis

The animals were examined for DENA-induced tumors in the liver. None of the mice from either control or HEEN groups developed liver tumors, whereas all the mice treated with DENA developed 100% liver carcinogenesis [Table 1]. However, pre-treatment with HEEN (at both doses) and ENF before intoxicated with DENA reduced liver tumor incidence to 0-33.33%. These results suggested that HEEN (at both doses) and ENF can prevent DENA-initiated tumor development in the mice liver tissue.
Table 1

Effect of DENA, HEEN, BHA (at both doses) and isolated flavonoid on DENA-induced hepatocarcinogenesis in Swiss albino mice

Effect of DENA, HEEN, BHA (at both doses) and isolated flavonoid on DENA-induced hepatocarcinogenesis in Swiss albino mice

Histopathological analysis of the liver tissue

Table 2 depicted the histo-pathological features seen in the liver of mice of different groups. The histological aspects showed normal hepatic tissue after administration of normal diet and water in the experimental duration of 31 days [Figure 1a–c]. Each lobule exhibited normal cellular architecture with thin walled central vein (CV) from which cords of distinct polyhedral hepatic cells (hepatocytes; H) each with well-preserved cytoplasm, prominent nucleus (N) and nucleolus radiated toward the lobule periphery [Figure 1b]. Nuclei were spherical or ovoid, with a regular surface and show considerable variation in size from cell to cell [Figure 1a and b]. Around the periphery of each lobule, portal canal was also present [Figure 1c]. It is a connective tissue septum that carries the branches of hepatic artery, hepatic and portal vein (HV and PV), bile duct and lymphatic vessels.
Table 2

Histopathological features seen in the liver of mice of different treatment groups

Figure 1

(a-c) Photomicrograph of transverse section of liver (H and E, ×40) of untreated Group I showing the normal hepatic cells, thin walled central vein, hepatic sinusoids (S; *), portal vein, hepatic artery and bile ducts

Histopathological features seen in the liver of mice of different treatment groups (a-c) Photomicrograph of transverse section of liver (H and E, ×40) of untreated Group I showing the normal hepatic cells, thin walled central vein, hepatic sinusoids (S; *), portal vein, hepatic artery and bile ducts DENA exposure produced significant tumor thrombi in both hepatic and portal vessels [Figure 1a and b]. The histologic appearance of HCC is also extremely variegated. The tumor cells in nests and thick cords and were separated from one another by thin walled sinusoids(S). Cytologically, the tomor cells bear some resemblance to normal hepatocytes, but are slightly larger, have more irregular and prominent nuclei [Figure 2a]. Many of the tumor cells contain intra-cytoplasmic violaceous, hyaline globules (arrow) that represents proteins produced by the tumor cells [Figure 2a]. The damaged hepatocyte cells with manifestations of extensive cytoplasmic vacuolization, broad patches of necrosis, damaged sinusoidal, massive fatty degeneration, swelling, ballooning degradation, broad infiltration of the lymphocytes, portal tract fibrosis with endothelial swelling and kuffer cells around the CV and the loss of cellular boundaries [Figure 2c and d] were also observed. In this group, the hepatic cords became distorted and the hepatocytes were bloated with large, spherical droplets of fat in a focal and/or diffuse manner in association with the dilatation and congestion of the central and PVs and infiltration of the parenchyma with inflammatory cells [Figure 2c]. These droplets pressed the nucleus toward the periphery giving a signet-ring appearance to the cell [Figure 2b]. Inflammation in the cells, congestion, sinusoids, blood cells pooling in sinusoidal spaces as well as in CV [Figure 2c and d] were also observed in DENA exposed group. Hepatocyte vacuolation and swelling, parenchyma disorganization, dilation of the inter hepatocyte space and hemorrhagic clots [Figure 2e] were also observed when compared with normal control animals (Group I). The nuclei of these cells were pyknotic and shrinked [Half Moon; Figure 2g]. Focal area of necrosis infiltrated with mononuclear cells (Nc) and degenerate nuclei were also seen [Figure 2f]. Space formation and high degree of vacuolation was also seen in liver tissue. Rarely, the bile ductules showed distention and proliferation. Furthermore, necrosis of the hepatocytes was mainly noticed around the portal area. It was observed that DENA caused a heavy destruction of the overall arrangement of liver cells because most of the cells were found in a ruptured state and without cytoplasm.
Figure 2

(a-g) Photomicrographs of transverse section of liver of N-nitrosodiethylamine-intoxicated mice (H and E, ×40) showing the distorted liver architecture and arrow indicated tumor cells contain intracytoplasmic violaceous, hyaline globules that represents proteins produced by the tumor cells (a). Damaged portal vein, hepatic artery and bile ducts (b), ruptured central vein (c and d), degenerate nuclei (N; f) with damage hyperchromatic malignant nuclei (HMN; e) and vacuoles (V; g) were also observed

(a-g) Photomicrographs of transverse section of liver of N-nitrosodiethylamine-intoxicated mice (H and E, ×40) showing the distorted liver architecture and arrow indicated tumor cells contain intracytoplasmic violaceous, hyaline globules that represents proteins produced by the tumor cells (a). Damaged portal vein, hepatic artery and bile ducts (b), ruptured central vein (c and d), degenerate nuclei (N; f) with damage hyperchromatic malignant nuclei (HMN; e) and vacuoles (V; g) were also observed Groups III [Figure 3a] and IV [Figure 3b] in comparison to carcinogen control exposed group (Group II) illustrated that HEEN extract at both doses retained hepatic architecture, recover the pattern of necrosis, fibrosis, hepatocyte vacuolation, fatty changes and hemorrhagic clots, incidence of inflammatory cells infiltration, centrilobular hepatocyte swelling. However, diminutive accumulation of fatty globules, distended bile ductile (DBD), dilated sinusoids, some hepatocytes showing an isokaryosis minimal inflammatory cell infiltration around the portal triads [Figure 3a]. The Group IV showed well-defined structure of hepatocytes with well-defined aggregation of HV and PV and absence of necrosis [Figure 3b].
Figure 3

(a-b) Photomicrograph of transverse section of liver (H and E, ×40) of Group III (a) and Group IV (b) showing normal architecture with some centrilobular swelling (a) and some lipid droplets (LD; b)

(a-b) Photomicrograph of transverse section of liver (H and E, ×40) of Group III (a) and Group IV (b) showing normal architecture with some centrilobular swelling (a) and some lipid droplets (LD; b) The liver sections of the mice treated with BHA at 0.5% [Figure 4a and b] before intoxicated with DENA did not show sign of protection whereas at higher dose of 1% [Figure 4c and d] normalize the hepatic cells and CV but failed to demonstrate protective activity as depicted in Figure 4c and d. Showing some neoplastically transformed cells, damaged cytoplasm, dispersed nuclei, dilated sinusoids, large blood pooling (BP) in CV and PV, DBD, lipid droplets (LD), pyknotic nuclei (PN), vacuolated cytoplasm, dense cytoplasm around HV and erythrocytes dispersed in cytoplasm and some hepatocytes showing an isokaryosis minimal inflammatory cell infiltration around the portal triads, many of the tumor cells contain hyaline globules (arrow) that represent protein produced by the tumor cells.
Figure 4

(a-d) A transverse section representation of liver of experimental Group V (a and b) and VI (c and d) showing damage cytoplasm, dispersed nuclei, dilated sinusoids, blood pooling, distended bile ductile, lipid droplets and pyknotic nuclei. Some hepatocytes showing an isokaryosis minimal inflammatory cell infiltration around the portal triads, many of the tumor cells contain hyaline globules (arrow) that represent protein produced by the tumor cells (H and E, ×40)

(a-d) A transverse section representation of liver of experimental Group V (a and b) and VI (c and d) showing damage cytoplasm, dispersed nuclei, dilated sinusoids, blood pooling, distended bile ductile, lipid droplets and pyknotic nuclei. Some hepatocytes showing an isokaryosis minimal inflammatory cell infiltration around the portal triads, many of the tumor cells contain hyaline globules (arrow) that represent protein produced by the tumor cells (H and E, ×40) The ENF (50 mg/kg body weight) treated Group VII [Figure 5] before intoxicated with DENA, showed a normal hepatic architecture with petite BP in PV, LD, PN, centrilobular swelling, dispersed erythrocytes in cytoplasm and some hepatocytes showed an leukocyte inflammatory cell infiltration around the portal triads. The cells were found to be arranged in the form of hepatic cords and the vein and bile canaliculi were also found to be normal to some extent.
Figure 5

A transverse section representation of liver of Euphorbia neriifolia flavonoid (50 mg/kg/day) pre-treated mice, before intoxicated with N-nitrosodiethylamine at (H and E, ×40) showing normal architecture with recovery

A transverse section representation of liver of Euphorbia neriifolia flavonoid (50 mg/kg/day) pre-treated mice, before intoxicated with N-nitrosodiethylamine at (H and E, ×40) showing normal architecture with recovery The higher dose (400 mg/kg body weight) of EN and ENF were more effective and were able to recover the injured liver to quite normal form when compared to ENL and BHA (at both doses). Hence, it can be assumed that the hepatoprotective activity by HEEN is dose dependent.

DISCUSSION

Liver plays an important role in the metabolism of drugs and it is the most vulnerable tissue for drug toxicity. According to the reports published by U.S. Food and Drug Administration, more than 900 drugs, toxins and herbs have been reported to cause liver injury. Drugs account for 20-40% of all instances of hepatic failure.[17] DENA, one of the most important environmental carcinogen and has been reported to cause the generation of ROS resulting in oxidative stress and cellular injury.[467121314] As liver is the major site of DENA metabolism, the production of active oxygen species in the liver may be responsible for its carcinogenic effects.[18] They have reported that a cell cycle disturbance induced in DENA-initiated hepatocytes by colchicine gives a growth advantage to putative preneoplastic lesions under conditions of partial hepatectomy and selection pressure and hence that a high incidence of HCCs can be obtained within a short latent period corroborating over present finding.[19] Observed results depict that the DENA exposed group showed 100% tumor incidence and these results are in agreement with aforementioned findings of previous workers.[2021] The results are also showed that administration of HEEN (at high dose) and ENF could prevent DENA-induced hepatic carcinogenesis in mice as no malignancies were seen in the animals. Histopathological examination of liver section of normal mice showed normal hepatic cells with well-defined cytoplasm and nucleus, whereas DENA exposed group showed liver cells were completely damaged and depicted pathological changes such as steatosis, centrilobular necrosis, large vacuolization, hyperchromatic malignant nuclei, hyperplastic nodules and obvious heteromorphism. These results are in confirmation with the findings of previous workers.[2021222324] The resulting effect was the production of elevated amounts of malondialdehyde and conjugated dienes, which caused deleterious effects on the membranous components of hepatocytes. HEEN (at both dose) and ENF pre-treatments before intoxicated with DENA (Groups III, IV and VII) showed the recovery process as indicated by the marked regenerative activity with mild necrosis (Day 31) and the cells became normal. The normalization of histo-architecture of liver damaged by DENA in ENL, ENH and ENF groups might be due to the trapping of ROS directly or indirectly by HEEN and flavonoid. Our results are in agreement with the previous report.[22] Observed results also revealed that BHA (at both dose) alone showed some mild distortion along with necrosis and swelling of the liver tissue as compared with the control group. BHA at both dose levels before intoxicated with DENA tried to revert, but not much extent as by HEEN and ENF group. The mice treated with the hydro-ethanolic extract and isolated flavonoid before intoxicated with DENA the normal cellular architecture was retained and it is more efficient than the standard BHA (at both dose) group, hence confirming the significant hepato protective effect of extract of HEEN at the dose of 150 and 400 mg/kg body weight and ENF at 50 mg/kg body weight, which is also confirmed by the results of biochemical studies.[67] In this study, E. neriifolia act as antioxidant agent as this plant contained wide range of active ingredients such as sugar, tannins, flavonoids, alkaloids,[78925] triterpenoids, tetracyclic triterpene (nerifoliene and euphol), triterpenoidal saponins etc.,[262728] which can inhibit or slow down the severity of cancer.[6781213142829] These active ingredients especially flavonoids, terpenoids and saponins neutralized free radicals and intermediates of metabolism that are highly reactive since they contain a non-paired electron[30] and to be responsible for the observed protective histological effects. The present study findings provide and validate the scientific evidence to the ethnomedicinal therapeutic use of this plant. The results presented in this study conclude that hepato-carcinogenesis, which was induced by DENA was effectively inhibited by 70% hydro-ethanolic (v/v) extract of E. neriifolia and by flavonoid isolated from ethanolic extract of E. neriifolia. The result could also be expressed in the order of ENH> ENF> ENL> BHAH> BHAL.
  16 in total

1.  Overall evaluations of carcinogenicity: an updating of IARC Monographs volumes 1 to 42.

Authors: 
Journal:  IARC Monogr Eval Carcinog Risks Hum Suppl       Date:  1987

2.  Protective role of Vitamin E pre-treatment on N-nitrosodiethylamine induced oxidative stress in rat liver.

Authors:  Anil K Bansal; Manju Bansal; Giridhar Soni; Deepak Bhatnagar
Journal:  Chem Biol Interact       Date:  2005-10-20       Impact factor: 5.192

3.  Chemopreventive effect of hydroethanolic extract of Euphorbia neriifolia leaves against DENA-induced renal carcinogenesis in mice.

Authors:  P Pracheta; Veena Sharma; Lokendra Singh; Ritu Paliwal; Sadhana Sharma; Sachdev Yadav; Shatruhan Sharma
Journal:  Asian Pac J Cancer Prev       Date:  2011

4.  Hepatoprotective activity of bacoside A against N-nitrosodiethylamine-induced liver toxicity in adult rats.

Authors:  Panneerselvam Janani; Kanakarajan Sivakumari; Chandrakesan Parthasarathy
Journal:  Cell Biol Toxicol       Date:  2008-08-05       Impact factor: 6.691

5.  Antihepatotoxic activity of Euphorbia neriifolia extract against N-nitrosodiethylamine-induced hepatocarcinogenesis in mice.

Authors:  Veena Sharma; Pracheta Janmeda; Ritu Paliwal; Shatruhan Sharma
Journal:  Zhong Xi Yi Jie He Xue Bao       Date:  2012-11

Review 6.  Antioxidant functions of carotenoids.

Authors:  N I Krinsky
Journal:  Free Radic Biol Med       Date:  1989       Impact factor: 7.376

7.  Emblica officinalis and hepatocarcinogenesis: a chemopreventive study in Wistar rats.

Authors:  Sarwat Sultana; Salahuddin Ahmed; Tamanna Jahangir
Journal:  J Ethnopharmacol       Date:  2008-03-30       Impact factor: 4.360

8.  Hepatic and renal oxidative stress in acute toxicity of N-nitrosodiethylamine in rats.

Authors:  A K Bansal; R Trivedi; G L Soni; D Bhatnagar
Journal:  Indian J Exp Biol       Date:  2000-09       Impact factor: 0.818

9.  Protective effects of garlic oil on hepatocarcinoma induced by N-nitrosodiethylamine in rats.

Authors:  Cui-Li Zhang; Tao Zeng; Xiu-Lan Zhao; Li-Hua Yu; Zhen-Ping Zhu; Ke-Qin Xie
Journal:  Int J Biol Sci       Date:  2012-02-22       Impact factor: 6.580

10.  Disturbance of the cell cycle with colchicine enhances the growth advantage of diethylnitrosamine-initiated hepatocytes in rats.

Authors:  M Tsutsumi; K Ohashi; T Tsujiuchi; E Kobayashi; K Kobitsu; H Kitada; T Majima; E Okajima; T Endoh; K Hasegawa; T Mori; Y Konishi
Journal:  Jpn J Cancer Res       Date:  1996-01
View more
  2 in total

Review 1.  Roles of Therapeutic Bioactive Compounds in Hepatocellular Carcinoma.

Authors:  Divya Jain; Yogesh Murti; Wasi Ullah Khan; Rajib Hossain; Mohammad Nabil Hossain; Krishn Kumar Agrawal; Rana Azeem Ashraf; Muhammad Torequl Islam; Pracheta Janmeda; Yasaman Taheri; Mohammed M Alshehri; Sevgi Durna Daştan; Balakyz Yeskaliyeva; Aliya Kipchakbayeva; Javad Sharifi-Rad; William C Cho
Journal:  Oxid Med Cell Longev       Date:  2021-10-31       Impact factor: 6.543

Review 2.  Flavonoids from the Genus Euphorbia: Isolation, Structure, Pharmacological Activities and Structure-Activity Relationships.

Authors:  Douglas Kemboi Magozwi; Mmabatho Dinala; Nthabiseng Mokwana; Xavier Siwe-Noundou; Rui W M Krause; Molahlehi Sonopo; Lyndy J McGaw; Wilma A Augustyn; Vuyelwa Jacqueline Tembu
Journal:  Pharmaceuticals (Basel)       Date:  2021-05-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.